|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2003-11-18
|
|
pubmed:abstractText |
As an effective regimen for isoniazid-resistant but rifampicin-susceptible tuberculosis (INHr-TB), the use of a 6-month three or four-drug treatment regimen including refampicin (or rifampin) and pyrazinamide has been recommended by many experts of the world. On the other hand, treatment regimen for rifampicin-resistant but isoniazide-susceptible tuberculosis (RFPr-TB) has not been well established because of the small number of such patients. In Japan the standard regimen has not been established even for INHr-TB, and the treatment has been done by each physician on the empirical bases.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0022-9776
|
|
pubmed:author |
pubmed-author:AkagawaShinobuS,
pubmed-author:BabaMotooM,
pubmed-author:HaraHiromichiH,
pubmed-author:KawabeYoshikoY,
pubmed-author:KurashimaAtsuyukiA,
pubmed-author:MachidaKazukoK,
pubmed-author:MasudaKimihikoK,
pubmed-author:MiyamotoMakiM,
pubmed-author:NagaiHideakiH,
pubmed-author:NagayamaNaohiroN,
pubmed-author:SaitoWakanaW,
pubmed-author:SuzukiJunkoJ,
pubmed-author:TamuraAtsuhisaA,
pubmed-author:YotsumotoHidekiH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
611-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14621568-Adult,
pubmed-meshheading:14621568-Aged,
pubmed-meshheading:14621568-Antitubercular Agents,
pubmed-meshheading:14621568-Cohort Studies,
pubmed-meshheading:14621568-Drug Therapy, Combination,
pubmed-meshheading:14621568-Female,
pubmed-meshheading:14621568-Humans,
pubmed-meshheading:14621568-Isoniazid,
pubmed-meshheading:14621568-Male,
pubmed-meshheading:14621568-Middle Aged,
pubmed-meshheading:14621568-Pyrazinamide,
pubmed-meshheading:14621568-Retrospective Studies,
pubmed-meshheading:14621568-Rifampin,
pubmed-meshheading:14621568-Treatment Outcome,
pubmed-meshheading:14621568-Tuberculosis, Multidrug-Resistant,
pubmed-meshheading:14621568-Tuberculosis, Pulmonary
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
|
|
pubmed:affiliation |
Department of Respiratory Medicine, Tokyo National Hospital, 3-1-1, Takeoka, Kiyoseshi, Tokyo 204-8585, Japan. wakana-s@tokyo.hosp.go.jp
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
